Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Unpublished trials ‘violates ethical obligation’ to patients

October 30, 2013 Research and Development, Sales and Marketing BMJ, Goldacre, all trials, trials

A new study published in the BMJ has found almost one in three (29%) of large clinical trials remain unpublished …
News

Aesica hires business development manager and director

October 30, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aesica, muganga

Contract development and manufacturing organisation (CDMO) Aesica has appointed Baali Muganga to the role of east coast US business development …
Appointment

‘Game-changing’ hep C pill gets FDA panel nod

October 29, 2013 Sales and Marketing FDA, Gilead, hep C, sofosbuvir

Gilead Science’s investigational hepatitis C drug sofosbuvir is one step closer to approval in the US after an FDA advisory …
News

Strong sales for Biogen Idec’s MS drug

October 29, 2013 Sales and Marketing Biogen IDEC, Q3, gilenya, tecfidera

Biogen Idec’s oral multiple sclerosis (MS) drug Tecfidera lived up to its blockbuster-in-waiting billing with third quarter sales that exceeded …
News

Amgen promotes two senior executives

October 29, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen

Amgen has promoted two senior executives as Brian McNamee becomes executive vice president and Stuart Tross senior vice president. McNamee …
Appointment

New online tool to hear lung cancer patients’ stories

October 29, 2013 Medical Communications, Sales and Marketing Boehringer, NSCLC, glcc, lung cancer

The Global Lung Cancer Coalition and Boehringer Ingelheim have teamed-up to increase awareness of the challenges facing individuals and families …
News

PMCPA: Sanofi ‘discredited pharma’

October 28, 2013 Medical Communications, Sales and Marketing ABPI, PMCPA, Sanofi, breach

Sanofi has lowered the public’s confidence in the pharma industry, according to the PMCPA, which enforces the ABPI Code of …
News

Positive CHMP verdicts for Actelion and Lundbeck

October 28, 2013 Sales and Marketing Actelion, CHMP, FDA, Lundbeck

Actelion and Lundbeck both took a step closer to EU approval for two drugs seen as pivotal to their future …
News

Strategic planning: don’t just do it, use it

October 28, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, craig, strategic planning

Every year, thousands of pharma employees spend endless hours in meetings discussing, building and presenting brand plans. Countless teams develop …
Feature

Sanofi starts C. diff study

October 28, 2013 Research and Development, Sales and Marketing C diff, Sanofi Pasteur, cdi, clostridium

Sanofi’s vaccines division is beginning a Phase III programme looking at the safety and effectiveness of an investigational treatment for …
News

Shire hires finance director

October 28, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, dominic blakemore

Dominic Blakemore will join Shire’s Board from January next year as a non-executive director and member of its Audit, Compliance …
Appointment

Sharon Hurley

October 25, 2013 Medical Communications, Sales and Marketing Med Comms

Synergy Vision expands client services team to meet demand in UK and Ireland Award-winning medical communications agency Synergy Vision is …
Appointment

Phoenix from Charnwood’s ashes

October 25, 2013 Research and Development, Sales and Marketing AstraZeneca, Charnwood, medilink

The shuttering of AstraZeneca’s R&D site at Charnwood in Leicestershire has had a positive effect on the region’s life sciences …
News

NICE ‘yes’ to Lucentis – with price cut

October 25, 2013 Sales and Marketing Dillon, Lucentis, NICE, Novartis

A price cut is the deal-breaking condition attached to NICE’s final draft guidance recommending Lucentis as an option for patients …
News

Banker joins Lilly Board

October 25, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing jackson tai, lilly

Eli Lilly has appointed ex-investment banker Jackson Tai to its Board to serve on the Audit and Finance Committee from …
Appointment
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026